Eldridge George A's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Dec 9, 2022
- Accession no.
- 0001415889-22-012355
- Filed
- Dec 9, 2022
- Trade date
- Dec 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $516.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eldridge George ACIK 0001413006 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | Common Stock | MOption exerciseAcquired | +11,637 | $2.14 | +$24,903.18 | 13,597 | Direct | |
| Dec 7, 2022 | Common Stock | SSaleDisposed | −7,079 | $19.37 | −$137,120.23 | 6,518 | Direct | |
| Dec 7, 2022 | Common Stock | SSaleDisposed | −4,558 | $20.40 | −$92,983.2 | 1,960 | Direct | |
| Dec 8, 2022 | Common Stock | MOption exerciseAcquired | +12,011 | $2.14 | +$25,703.54 | 13,971 | Direct | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −960 | $20.12 | −$19,315.2 | 13,011 | Direct | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −20 | $20.58 | −$411.6 | 12,991 | Direct | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −11,031 | $24.20 | −$266,950.2 | 1,960 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | Common Stock | MOption exerciseDisposed | −11,637 | $0.00 | $0 | 84,656 | Direct | |
| Dec 8, 2022 | Common Stock | MOption exerciseDisposed | −1,887 | $0.00 | $0 | 82,769 | Direct | |
| Dec 8, 2022 | Common Stock | MOption exerciseDisposed | −10,124 | $0.00 | $0 | 40,726 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.